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Neisseria meningitidis is a human-restricted bacterium that can invade the bloodstream and 18 
cross the blood-brain barrier resulting in life-threatening sepsis and meningitis. Meningococci 19 
express a cytoplasmic peroxiredoxin-glutaredoxin (Prx5-Grx) hybrid protein that has also 20 
been identified on the bacterial surface. Here, recombinant Prx5-Grx was confirmed as a 21 
plasminogen (Plg)-binding protein, in an interaction which could be inhibited by the lysine 22 
analogue ϵ-aminocapronic acid. rPrx5-Grx derivatives bearing a substituted C-terminal lysine 23 
residue (rPrx5-GrxK244A), but not the active site cysteine residue (rPrx5-GrxC185A) or the sub-24 
terminal rPrx5-GrxK230A lysine residue, exhibited significantly reduced Plg-binding. The 25 
absence of Prx5-Grx did not significantly reduce the ability of whole meningococcal cells to 26 
bind Plg, but under hydrogen peroxide-mediated oxidative stress, the N. meningitidis Δpxn5-27 
grx mutant survived significantly better than the wild-type or complemented strains. 28 
Significantly, using human whole blood as a model of meningococcal bacteremia, it was 29 
found that the N. meningitidis Δpxn5-grx mutant had a survival defect compared with the 30 
parental or complemented strain, confirming an important role for Prx5-Grx in 31 
meningococcal pathogenesis.  32 
 33 
Keywords: Neisseria meningitidis; protein moonlighting; peroxiredoxin; pathogenesis; whole 34 
blood model; plasminogen 35 
 36 
Highlights: 37 
 Meningococcal Prx5-Grx interacts with plasminogen via a C-terminal lysine residue 38 
 Loss of Prx5-Grx does not reduce the ability of meningococci to bind Plg 39 
 Loss of Prx5-Grx enhances meningococcal survival under oxidative stress 40 
 Loss of Prx5-Grx results in a survival defect in human whole blood   41 
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1. Introduction  42 
Neisseria meningitidis is an important cause of sepsis and meningitis in susceptible 43 
individuals, with the majority of cases occurring in children and young adults. The organism 44 
frequently colonizes the nasopharynx asymptomatically and is transmitted from person-to-45 
person by close contact [1]. Rarely, however, hypervirulent strains may invade the mucosal 46 
epithelial barrier to reach subcutaneous tissues and subsequently enter the bloodstream [2]. 47 
The ability of the meningococcus to survive in subcutaneous tissues and blood is therefore a 48 
prerequisite for invasive meningococcal disease. Various meningococcal components are 49 
known to be essential for, or enhance, survival in non-immune blood, including capsular 50 
polysaccharide [3, 4], lipooligosaccharide (LOS) [5], the factor H-binding proteins (fHbp and 51 
NspA) [5-8] and NalP [8, 9]. Various detoxifying enzymes are also used by N. meningitidis to 52 
protect against reactive oxygen and nitrogen species produced by polymorphonuclear (PMN) 53 
cells and monocytes/macrophages [10, 11]. Up-regulation of catalase (Kat), superoxide 54 
dismutase (Sod) and nitrite reductase (AniA) have been demonstrated following incubation in 55 
human blood [8]. SodC has previously been shown to protect N. meningitidis from 56 
phagocytosis [12] and AniA protects N. gonorrhoeae in human serum [13], however Kat was 57 
shown not to be required for meningococcal survival in human blood [8].  58 
Peroxiredoxins (Prxs) are a large family of cysteine-based peroxidases, present in all 59 
kingdoms of life, that catalyse the reaction ROOH+2e- → ROH+H2O and reduce hydrogen 60 
peroxide (H2O2), peroxynitrite and a wide range of organic hydroperoxide compounds [14-61 
16]. Prxs are ubiquitous and abundant proteins that are important for antioxidant defence and 62 
the regulation of cell signalling pathways [17, 18]. Prxs can be divided into six subfamilies 63 
(AhpC-Prx1, BCP-PrxQ, Tpx, Prx5, Prx6 and AhpE) with distinct amino acid sequences, but 64 
all contain an absolutely conserved active site cysteine in the motif P-XXX-T(S)-XX-C, 65 
which reacts with H2O2 to form a cysteine sulfenic acid [19]. Prxs are described as either 1-66 
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Cys Prx or 2-Cys Prx, depending on whether a second cysteine residue participates in the 67 
enzymatic reaction [19]. The 2-Cys Prxs are further subdivided into ‘typical’ and ‘atypical’ 68 
forms, depending on the location of the second cysteine residue; in typical forms the second 69 
cysteine is found in the C-terminus of the partner subunit, whereas in atypical enzymes it is 70 
located at other positions [19]. Glutaredoxins (Grxs) are small redox enzymes that use 71 
glutathione (GSH) as a cofactor [20]. Grxs possess an active site disulfide bond, which exists 72 
in either a reduced or an oxidized form. Grxs act as antioxidants by reducing 73 
dehydroascorbate, peroxiredoxins and methionine sulfoxide reductase. Some bacterial species 74 
contain tetrameric Prx5-Grx hybrid enzymes in which the C-terminal Grx domain acts as an 75 
electron donor for the N-terminal Prx domain [21].  76 
Prx enzymes are increasingly being recognized as multifunctional or moonlighting 77 
proteins, which are involved in various aspects of bacterial survival and pathogenesis. In 78 
Helicobacter pylori, a BCP-PrxQ subfamily Prx was found to contribute to resistance to 79 
oxidative stress and host colonization [22] and an AhpC-Prx1 subfamily Prx was shown to 80 
oligomerise and acquire protein chaperone activity under oxidative stress conditions [23]. In 81 
Haemophilus influenzae, a Prx-Grx hybrid enzyme was found to be expressed preferentially 82 
during growth in biofilms [24]. A mutant strain was more susceptible to organic 83 
hydroperoxides [25] and showed persistence defects in a chinchilla model of otitis media and 84 
a murine model of chronic obstructive pulmonary disease [26]. In Streptococcus agalactiae, a 85 
similar AhpC-Prx1 enzyme was shown to bind haem and participate in its intracellular 86 
availability [27]. In Coxiella burnetii, a BCP-PrxQ Prx was shown to bind DNA and protect 87 
the organism from oxidative stress during the exponential phase of growth [28]. A Prx6 88 
subfamily protein, LsfA, in Pseudomonas aeruginosa, was found to reduce the oxidative 89 
burst in macrophages and to be important for virulence in a murine model of pneumonia [29]. 90 
In Vibrio vulnificus, Prx3, a Grx3/GSH-dependent 1-Cys Prx, was shown to be required for 91 
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optimal growth in medium containing peroxides and the Prx3 mutant strain was less virulent 92 
in mice [30]. A 1-Cys Prx6 enzyme from Thermococcus kodakarensis, a thermophilic 93 
anaerobic archaeon, was found to act as a molecular chaperone that blocked oxidative stress-94 
mediated aggregation of proteins and DNA [31]. More recently, an AhpC-Prx1 subfamily Prx 95 
of F. tularensis LVS was shown to confer resistance against a wide range of reactive oxygen 96 
and nitrogen species, and to serve as a virulence factor. In the highly virulent strain, F. 97 
tularensis SchuS4, the enzyme also enhanced intra-macrophage survival [32]. 98 
N. meningitidis contains a Prx-Grx hybrid atypical 2-Cys enzyme in the Prx5 99 
subfamily and a BCP-PrxQ subfamily Prx (designated NMB0946 and NMB0750, 100 
respectively, in strain MC58) [19, 33]. The Prx5-Grx hybrid enzyme was previously found to 101 
be a putative moonlighting protein present on the meningococcal cell surface where it 102 
contributes to plasminogen (plg)-binding [34] and in N. gonorrhoeae, the Prx5-Grx 103 
orthologue was found to play a role in biofilm formation [35]. In this study, we examine the 104 
properties and role of Prx5-Grx in meningococcal pathogenesis. We confirm that Prx5-Grx 105 
moonlights on the bacterial surface and show that a single lysine residue in the penultimate 106 
C-terminal position in Prx5-Grx is required for optimal interactions with human plasminogen. 107 
Importantly, we also demonstrate that Prx5-Grx is required for meningococcal survival in 108 
human non-immune whole blood.  109 
 110 
2. Experimental procedures  111 
2.1. Bacterial strains and culture conditions 112 
Escherichia coli JM109 (Promega) was used as a host strain for the expression of 6 × 113 
histidine-tagged rPrx5-Grx and for mutagenic plasmid construction. E. coli XL10-Gold ultra-114 
competent cells (Agilent Technologies) were used for site-directed mutagenesis of rpsL. NEB 115 
5-alpha competent cells were used for cloning of Gibson assembly reactions. All E. coli 116 
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strains were grown at 37°C in Lysogeny Broth (LB) or on LB agar supplemented, where 117 
appropriate, with ampicillin (100 µg ml-1), kanamycin (30 µg ml-1) or erythromycin (200 µg 118 
ml-1). Strains of Neisseria meningitidis (Table S1) were grown at 37°C in air plus 5% CO2 on 119 
Columbia agar with chocolated horse blood (Thermo Fisher Scientific), Brain Heart Infusion 120 
(BHI) agar or BHI broth supplemented with 1% Vitox (Thermo Fisher Scientific) and 121 
kanamycin (50 µg ml-1), streptomycin (100 µg ml-1) or erythromycin (5 µg ml-1), where 122 
appropriate. 123 
 124 
2.2. Construction of plasmids encoding recombinant Prx5-Grx 125 
The prx5-grx gene was amplified from N. meningitidis MC58 using oligonucleotides 126 
NMB0946F1 and NMB0946R1 (Table S2) using Phusion High-Fidelity DNA polymerase 127 
(New England Biolabs). After digestion with BamHI, the PCR product was ligated into 128 
BamHI-digested pQE30 to yield pMAJ2 (Table S3). The Prx5-Grx lysine residues (230K, 244K 129 
and 230K/244K) and the glutaredoxin active-site cysteine residue (185C) were replaced by 130 
alanine residues using the Q5 Site-Directed Mutagenesis Kit (New England BioLabs) 131 
following the manufacturer’s instructions, yielding pMAJ2-230KA, pMAJ2-244KA, pMAJ2-132 
230244KKAA and pMAJ2-185CA, respectively (Table S3). Oligonucleotides used are given 133 
in Table S2. 134 
 135 
2.3. Recombinant Prx5-Grx expression and purification 136 
E. coli JM109 strains were grown to log phase, induced with 0.5 mM isopropyl β-D-1-137 
thiogalactopyranoside (IPTG) for 3 h, and harvested by centrifugation (4,200 × g for 10 min). 138 
Recombinant 6 × histidine-tagged proteins were then affinity-purified under native 139 
conditions. Briefly, E. coli cell pellets were resuspended in 30 ml lysis/wash buffer (50 mM 140 
NaH2PO4, 300 mM NaCl, 40 mM imidazole, pH 7.4) followed by sonication using an MSE 141 
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SoniPrep 150 sonicator for 8 cycles (30s on, 30s off) on ice. The cell lysate was centrifuged 142 
(4,500 × g for 15 min) and the cleared lysate was loaded onto a HisTrap FF column (GE 143 
Healthcare Lifesciences) pre-packed with Ni Sepharose 6 Fast Flow (GE Healthcare 144 
Lifesciences) connected to a ÄKTAprime plus liquid chromatography system (GE Healthcare 145 
Lifesciences), equilibrated with 10 column volumes of lysis/wash buffer. Proteins were 146 
eluted by step elution using elution buffer (50 mM NaH2PO4, 300 mM NaCl, 300 mM 147 
imidazole, pH 7.4). A HiTrap column pre-packed with five millilitres of Sephadex G-25 148 
Superfine (GE Healthcare Lifesciences) equilibrated with 5 column volumes of phosphate 149 
buffered saline (PBS) was used for buffer exchange. Glycerol at a final concentration of 10% 150 
was added to inhibit aggregation. A pre-packed Superdex column (GE Healthcare 151 
Lifesciences) mounted on an ÄKTAprime plus liquid chromatography system was then used 152 
to carry out gel filtration, following the manufacturer’s instructions. After equilibration with 153 
150 ml PBS containing 10% glycerol, the IMAC-purified protein sample was injected into 154 
the column. Fractions contained the purified protein were collected and concentrated using 155 
Vivaspin sample concentrators (Sartorius; 10,000 MWCO).  156 
 157 
2.4. Production of a rabbit antiserum against rPrx5-Grx  158 
Rabbit anti-Prx5-Grx antibodies were raised in a New Zealand White female rabbit 159 
immunized subcutaneously four times at 2-week intervals with 100 µg of rPrx5-Grx protein 160 
emulsified in Freud’s complete (first immunization only) or incomplete adjuvant. After three 161 
injections, the animal was test bled, boosted once more and sacrificed 7 days later.  162 
 163 
2.5. SDS-PAGE and immunoblotting 164 
Proteins were electrophoretically separated using 10% polyacrylamide gels (Mini-165 
Protean III; Bio-Rad) and stained using SimplyBlue™ SafeStain (Thermo Fisher Scientific) 166 
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or transferred to nitrocellulose membranes using a Trans-Blot SD semidry transfer cell (Bio-167 
Rad) according to the manufacturer's recommendations. Membranes were probed with mouse 168 
anti-pentahistidine antibody (Qiagen) or rabbit anti-Prx5-Grx primary antibody (RαPrx5-Grx) 169 
diluted 1:10,000 or 1:1,000, respectively, in blocking buffer (5% [w/v] non-fat dry milk, 170 
0.1% [v/v] Tween 20 in 1 × PBS) and incubated for 2 h. After washing in PBS with 0.1% 171 
Tween 20 (PBST), membranes were incubated for 2 h with 1:10,000-diluted goat anti-mouse 172 
(or anti-rabbit) IgG-alkaline phosphatase conjugate (Sigma). After washing with PBST, blots 173 
were developed using BCIP/NBT-Blue liquid substrate (Sigma).  174 
 175 
2.6. ELISA 176 
Microplate wells (Nunc 96-well plates, PolySorp) were coated with 20 pmol glu-plg 177 
(human plasma; Calbiochem), laminin (human placenta; Merck Millipore), fibronectin 178 
(human plasma; Sigma), collagen I (human placenta; Corning) or 1% BSA in sodium 179 
carbonate buffer (142 mM NaHCO3, 8 mM Na2SO3, pH 9.0) and incubated overnight at 4°C. 180 
After washing with PBS-Tween 20 (0.05%; PBST), wells were blocked with 1% BSA in PBS 181 
for 1 h. After removal of the blocking solution, 50 pmol rPrx5-Grx in 1% BSA/PBS was 182 
added and incubated for 1 h. Following vigorous washing with PBST, RαPrx5-Grx (diluted 183 
1:2,000 in 1% BSA/PBS) was added for incubation for 1 h. Plates were again vigorously 184 
washed, before the addition of goat anti-rabbit IgG-alkaline phosphatase conjugate (Sigma; 185 
diluted 1:20,000 in 1% BSA/PBS), was added and incubated for 1 h. Plates were again 186 
vigorously washed, and the color was developed by adding phosphatase substrate (Sigma), 187 
dissolved in buffer containing 0.1 M glycine, 1 mM ZnCl2 and 1 mM MgCl2, pH 10.4, into 188 
each well and absorbance at 405nm was measured using a Biotek EL800 spectrophotometer. 189 
Alternatively, binding assays were undertaken as above, but using rPrx5-Grx (5 pmol) or 1% 190 
BSA as the immobilized ligand to capture glu-plg (5 pmol). Bound glu-plg was detected 191 
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using goat anti-human plg (1:10,000; Rockland Immunochemical) and donkey anti-goat IgG-192 
alkaline phosphatase conjugate (1:5,000; Promega). The lysine analogue, ε-aminocaproic 193 
acid (EACA; 50 mM) (Sigma) was utilized for inhibition studies. 194 
 195 
2.7. Generation of MC58 rpsL- and MC58 KanR rpsL+ rpsL- 196 
A 2.5-kb fragment consisting of rpsL and flanking DNA was amplified from 197 
N. meningitidis MC58 using oligonucleotides rpsL-FlankF and rpsL-FlankR (Table S2). The 198 
amplified gene was TA-cloned into pCR4-TOPO to generate plasmid pCF4-TOPOΔrpsL, 199 
which was subjected to site-directed mutagenesis, designed to replace 43K with T, using the 200 
primers rpsLSD-F and rpsLSD-R (Table S2) and the QuikChange Lightning Site-Directed 201 
Mutagenesis Kit (Agilent Technologies) according to the manufacturer’s protocol. Following 202 
mutagenesis, the reaction was incubated with DpnI to digest non-mutated parental DNA prior 203 
to transformation of E. coli XL10-Gold ultra-competent cells. A plasmid extracted from a 204 
resulting clone was sequenced and confirmed to contain the desired mutation and designated 205 
pCR4-TOPOΔrpsLT and used to transform N. meningitidis MC58. Genomic DNA from a 206 
resulting clone was sequenced, the desired mutation confirmed, and the resulting mutant 207 
designated MC58 rpsL- (Table S1). 208 
An MC58 derivative containing a cassette consisting of a kanamycin resistance gene 209 
and a wild-type rpsL gene was generated using a protocol based on that described by Gibson 210 
[36]. Primer pairs Upstream343_F and Upstream343_R; Downstream343_F and 211 
Downstream343_R; rspL_F and rspL_R (Table S2) were designed using the web tool 212 
NEBuilder to amplify fragments with appropriate overlaps required for assembly of 213 
fragments corresponding to regions upstream and downstream of the gene NMB0343 and the 214 
rpsL gene from chromosomal DNA of N. meningitidis strain MC58. The aphA-3 gene of 215 
plasmid pJMK30 [37] was amplified using the primers Kan cassette_F and Kan cassette_R 216 
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and all four fragments, together with pUC19 plasmid DNA linearized with EcoRI and 217 
BamHI, was performed using 0.2-0.25 pmol of each DNA fragment, 10 µl of 2 × Gibson 218 
assembly master mix (NEB) and dH2O to 20 µl. After incubation at 50˚C, the assembly 219 
reaction was used to transform NEB 5-alpha competent E. coli cells (NEB). The resulting 220 
plasmid was subsequently used to transform MC58 rpsL- by selection for kanamycin 221 
resistance and screening for streptomycin sensitivity. The resulting strain was designated 222 
MC58 KanR rpsL+ rpsL- (Table S1). 223 
 224 
2.8. Construction of a markerless prx5-grx mutant  225 
A 2.7-kb fragment consisting of prx5-grx and flanking DNA was amplified using 226 
oligonucleotides UprxDF1 and UprxDR1 (Table S2) from N. meningitidis MC58. The 227 
amplified DNA was TA-cloned into pGEM-T Easy to generate pGUD1 (Table S3). This was 228 
then subjected to inverse PCR using oligonucleotides DeprxF1 and DeprxR1 (Table S2) 229 
resulting in the amplification of a ca. 5-kb amplicon in which the prx5-grx coding sequence 230 
was deleted and a unique BamHI restriction site had been introduced. The BamHI site was 231 
used to introduce a DNA fragment containing a kanamycin resistance cassette and rpsL+ (a 232 
dominant selectable marker) which was generated by PCR from N. meningitidis MC58 KanR 233 
rpsL+ rpsL- (Table S1) using oligonucleotides KnsLF1 and KnsLR1 (Table S2), in place of 234 
prx5-grx, resulting in plasmid pGUD2. Plasmid pGUD3 was generated by self-ligation of the 235 
same inverse PCR product. 236 
pGUD2, containing the resistance cassette in the same orientation as the deleted gene, 237 
was subsequently used to mutate meningococcal strain MC58 rpsL- by natural transformation 238 
and allelic exchange as previously described [38] generating MC58 KanR rpsL+ rpsL- prx5-239 
grx. pGUD3 was then used mutate MC58 KanR rpsL+ rpsL - prx5-grx to generate the 240 




2.9. Complementation of prx5-grx 243 
A fragment corresponding to the prx5-grx coding sequence and upstream sequence was 244 
amplified from strain MC58 using oligonucleotides PerCompF1 and PerCompR1 (Table S2) 245 
incorporating BglII sites into the amplified fragment. The BglII-digested fragment was then 246 
introduced into a unique BglII-site in pYHS25 (Table S3). This vector contains an 247 
erythromycin resistance gene flanked by the MC58 genes NMB0102 and NMB0103. The 248 
resulting plasmid, pLD1, was used to transform MC58 rpsL- Δprx5-grx by natural 249 
transformation, thus introducing a single chromosomal copy of prx5-grx and the downstream 250 
erythromycin resistance cassette into the intergenic region between NMB0102 and 251 
NMB0103, generating MC58 rpsL- Δprx5-grx prx5-grxECT.  252 
 253 
2.10. Whole cell ELISA 254 
Mid-log phase (OD600 ≥ 0.5) liquid cultures of meningococcal strains were 255 
centrifuged at 2087 × g at 4°C for 10 min. After discarding the supernatant, the bacterial 256 
pellet was washed twice with sterile-filtered PBS and resuspended in 0.5% v/v formaldehyde 257 
in PBS. The cells were incubated at 4°C for 30 min with gentle agitation. Cells were then 258 
centrifuged at 2087 × g for 10 min at 4°C, washed one more time with PBS, resuspended in 259 
sodium carbonate buffer and the OD600 adjusted to 0.2. 100 μl aliquots of formaldehyde-fixed 260 
meningococcal cells in carbonate buffer were then used to coat microplate wells overnight at 261 
4˚C with gentle agitation. Plates were then washed three times with PBST and further steps 262 
were carried out as described in section 2.6.  263 
 264 
2.11. Hydrogen peroxide survival assay 265 
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Sensitivity to hydrogen peroxide stress was determined by a method based on that 266 
described by Tala et al [39]. Briefly, meningococcal strains were grown to mid-log phase 267 
(OD600 ≥ 0.5). Suspensions were then adjusted to ca. 10
8 CFU ml-1 (confirmed retrospectively 268 
by plating out serially diluted aliquots). 100 μl aliquots of the meningococcal cell suspension 269 
were added to a sterile 96-well polystyrene round bottom microwell plate (Thermo Fisher 270 
Scientific) containing 150 μl BHI. Fifty microliters of H2O2 was then added to yield a final 271 
concentration of 12.5 mM, and the plate was incubated at 37°C in 5% CO2 atmosphere with 272 
gentle shaking for 1 h. At 20 min intervals, 10 μl aliquots were taken, serially diluted, and 273 
plated out. After overnight incubation at 37°C in 5% CO2, colonies were counted and 274 
expressed as CFU ml-1.  275 
 276 
2.12. Ex vivo human whole blood model of bacteremia  277 
Whole venous blood was collected from healthy individuals (not immunized against N. 278 
meningitidis) and supplemented with heparin (17 IU ml-1) to inhibit coagulation. 279 
Meningococci were grown to mid-log phase and then diluted in BHI broth to approximately 280 
108 CFU ml-1. The assay was started by the addition of 190 μl whole human blood to 10 μl of 281 
bacterial suspension. Suspensions were incubated at 37°C and 5% CO2 with gentle agitation 282 
for 2 h and at various time points an aliquot of the sample was removed and the number of 283 
viable CFU determined by plating out of serial dilutions.   284 
 285 
3. Results 286 
3.1. Prx5-Grx is a plasminogen-binding protein  287 
To examine putative host ligand-binding functions of meningococcal Prx5-Grx, and to 288 
raise specific antibodies, prx5-grx from the group B meningococcal strain MC58 was 289 
expressed in E. coli and purified under non-denaturing conditions to yield N-terminally 6 × 290 
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histidine-tagged recombinant Prx5-Grx (Fig. S1). Since surface-localized bacterial 291 
moonlighting proteins are recognized to bind a variety of host proteins [40] we screened the 292 
ability of rPrx5-Grx to bind to human plasminogen (glu-plg), fibronectin, laminin and 293 
collagen. Of these potential ligands, Prx5-Grx was only able to significantly bind to glu-plg 294 
(Fig. 1A). Binding to glu-plg could be inhibited by the lysine analogue, ɛ-aminocaproic acid 295 
(EACA) (Fig. 1B).  296 
 297 
3.2. Lysine 244 is required for optimal binding of meningococcal Prx5-Grx to plasminogen 298 
Given the likely involvement of lysine residues in the binding of rPrx5-Grx to glu-plg, 299 
the two C-terminal lysine residues (230K and 244K) of rPrx5-Grx were individually, or in 300 
combination, replaced with alanine using site-directed mutagenesis and the effects on glu-plg 301 
binding were examined. rPrx5-GrxK244A exhibited a significantly reduced ability to bind 302 
glu-plg, confirming an important role for this lysine residue at the penultimate position in 303 
meningococcal Prx5-Grx (Fig. 2). In contrast, mutation of 230K had no significant effect on 304 
glu-plg binding, while the double lysine mutant behaved similarly to the 244K mutant (Fig. 2). 305 
No statistically significant difference in glu-plg binding was apparent in assays utilizing 306 
rPrx5-GrxC185A, in which the second cysteine residue of the Grx active site was substituted, 307 
confirming that glutaredoxin activity is not required for the binding of glu-plg (Fig. 2).  308 
 309 
3.3. Generation of prx5-grx knock out and complemented strains   310 
To examine the roles of Prx5-Grx in the meningococcus, a knockout derivative of N. 311 
meningitidis MC58 was generated using a markerless mutation strategy. Briefly, prx5-grx 312 
plus flanking DNA was cloned and inverse PCR used to remove the entire ORF. The product 313 
was then ligated to a DNA fragment harbouring a kanamycin resistance cassette plus the 314 
dominant marker, rpsL+, (conferring streptomycin sensitivity), and the resulting plasmid used 315 
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to transform a streptomycin-resistant N. meningitidis MC58 derivative (MC58 rpsL-) yielding 316 
MC58 KanR rpsL+ rpsL- Δprx5-grx. The latter strain was then further transformed using the 317 
self-ligated inverse PCR product to yield the final streptomycin resistant, but markerless 318 
MC58 rpsL- Δprx5-grx mutant. Immunoblotting using RαPrx5-Grx showed that a ca. 27-kDa 319 
protein corresponding to Prx5-Grx could be detected in whole cell lysates of wild-type but 320 
not MC58 rpsL- Δprx5-grx (Fig. S2), confirming that expression had been abolished in the 321 
mutant. To further confirm that the ca. 27-kDa immuno-reactive protein was Prx5-Grx, a 322 
wild-type copy of prx5-grx was introduced in trans into MC58 rpsL- Δprx5-grx restoring 323 
Prx5-Grx expression, albeit at lower expression levels than the wild-type (Fig. S2). 324 
 325 
3.4. Loss of Prx5-Grx does not significantly reduce the ability of meningococci to bind 326 
plasminogen   327 
A whole cell ELISA assay suggested localisation of meningococcal Prx5-Grx on the 328 
surface of wild-type, MC58 rpsL- and the complemented mutant (Fig. 3), with the latter 329 
exhibiting reduced levels of anti-Prx5-Grx reactivity compared to the parental strain in line 330 
with reduced overall Prx5-Grx expression. Importantly, there was no significant difference in 331 
the Plg-binding ability of Δprx5-grx compared to strains expressing surface-exposed Prx5-332 
Grx (Fig. 4) consistent with previous observations that meningococci possess a range of 333 
surface-exposed glu-plg ligands which may be functionally redundant [34, 41].  334 
 335 
3.5. Prx-Grx-deficient meningococci are protected from killing in a hydrogen peroxide assay 336 
Given the likely involvement of Prx5-Grx in oxidative stress responses, hydrogen 337 
peroxide (H2O2) killing assays were performed. After 20 min of exposure to H2O2, survival of 338 
MC58 rpsL- prx5-grx was significantly enhanced compared to the parental or 339 
complemented strains (Fig. 5). With the exception of the prx5-grx mutant, each strain tested 340 
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was undetectable at the 40 and 60 min time points. In contrast, growth curve assays carried 341 
out in the absence of H2O2 showed no significant differences between strains (Fig. S3). Taken 342 
together, the absence of Prx5-Grx expression had no effect on in vitro growth under standard 343 
conditions, but Prx-Grx-deficient meningococci were protected from killing when exposed to 344 
H2O2.  345 
 346 
3.6. Prx5-Grx is important for survival in an ex vivo human whole blood model of 347 
meningococcal septicemia 348 
An ex vivo human whole blood model of meningococcal bacteremia was used to 349 
assess the contribution of Prx5-Grx to survival on exposure to cellular and humoral 350 
mechanisms of killing. In both donors tested, there was a ≥ 2-log10 difference in CFU 351 
between MC58 rpsL- prx5-grx and the parental strain at 30 and 60 min time points. Survival 352 
of the complemented mutant was similar to that of the parental strain, suggesting that even 353 
the lower level of expression of Prx5-Grx observed in the complemented strain was sufficient 354 
to provide full protection against killing in human blood (Fig. 6).  355 
 356 
4. Discussion 357 
Prx5-Grx is a highly conserved protein in Neisseria species [42] and a previous study 358 
demonstrated that both the Prx and Grx domains are biochemically functional in the 359 
meningococcal enzyme [33]. Prx5-Grx is upregulated in response to heat shock in N. 360 
meningitidis [43] and a deletion mutant in N. gonorrhoeae was found to have a defect in 361 
biofilm formation [35]. In N. meningitidis, Prx5-Grx was also identified as a putative plg-362 
binding protein on the bacterial surface [34]. In this study, we confirm that Prx5-Grx is a 363 
multifunctional protein with plg-binding activity, but show that it is functionally redundant 364 
on the bacterial cell surface in the presence of alternative plg-binding proteins. Importantly, 365 
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we demonstrate that Prx5-Grx is also required, however, for survival of N. meningitidis in 366 
non-immune blood. 367 
Having confirmed that meningococcal Prx5-Grx is able to bind human plg, we 368 
investigated which amino acid residues in Prx5-Grx were required for the plg-binding. We 369 
observed that binding of plg was sensitive to the lysine analogue EACA, suggesting that 370 
certain lysine residues in Prx5-Grx were responsible for the interaction. Knaust et al. reported 371 
that internal lysine residues (rather than the lysine residues in terminal or penultimate 372 
positions) might be important for plg-binding by enolase, DnaK and Prx5-Grx [34]. In 373 
contrast, we demonstrated that the lysine residue in the penultimate position in Prx5-Grx 374 
rather than an internal lysine residue was primarily responsible for plg-binding. The 375 
difference in findings may be explained by our use of an EIA-based assay to detect plg-376 
binding to non-denatured rPrx5-Grx rather than a dot blot assay, or possibly the replacement 377 
of both the penultimate lysine residue and the asparagine residue in the terminal position of 378 
Prx5-Grx in the study by Knaust et al [34].  379 
N. meningitidis normally inhabits the mucosal surface of the human nasopharynx or 380 
subcutaneous tissues. In these niches, meningococcal cells are continuously exposed to 381 
reactive oxygen species (ROS), produced by internal metabolic functions as a natural by-382 
product of aerobic respiration, by other commensal microorganisms, or by host metabolism 383 
and immune responses, and must adapt rapidly to varying levels of oxidative stress [44]. In 384 
the upper respiratory tract (and in the bloodstream), macrophages and polymorphonuclear 385 
cells, which utilize oxygen-dependent pathways to generate large quantities of ROS, facilitate 386 
the clearance of invading organisms [45].  387 
The response to oxidative stress in pathogenic Neisseria is controlled by the OxyR 388 
regulon, which has been studied in N. gonorrhoeae [35], N. meningitidis [46] and 389 
H. influenzae [47], and has been shown to operate in a distinctive manner in these organisms 390 
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compared to the OxyR regulon in Escherichia coli. The OxyR regulon controls expression of 391 
kat in response to H2O2 [48, 49], however, it was found that oxyR mutant strains of 392 
N. gonorrhoeae [35, 50], N. meningitidis [46] and H. influenzae [47] have considerably 393 
higher levels of kat expression and are significantly more resistant to H2O2 killing than their 394 
respective wild-type strains. In N. gonorrhoeae, the OxyR regulon was suggested to be 395 
limited to kat and two other genes: prx (designated prx5-grx in this study) and the 396 
downstream gene, gor [35]. In H. influenzae, the Prx5-Grx homologue was suggested to be 397 
involved in scavenging low levels of endogenous H2O2, thus limiting the activation of kat, 398 
and, thereby, enabling the response to oxidative stress to be tightly controlled at a level 399 
proportionate to the stress [25, 47]. In this study, we found that the meningococcal prx5-grx 400 
mutant is also more resistant to exogenously supplied H2O2 compared to the wild-type and 401 
complemented strains, which is in keeping with the findings described in N. gonorrhoeae and 402 
H. influenzae [25, 35]. Increased catalase expression was determined in both the N. 403 
gonorrhoeae and H. influenzae mutants lacking Prx5-Grx expression and suggested as a 404 
likely explanation for increased H2O2 resistance [25, 35]. Further experimentation will be 405 
required to establish if catalase expression is also elevated in the meningococcal prx5-grx 406 
mutant. Interestingly, in H. influenzae, the majority of scavenging of metabolically-generated 407 
H2O2 was shown to be due to expression of kat or the prx5-grx homologue, however, deletion 408 
of both genes did not impair virulence in the infant rat model of infection [51]. 409 
Ex-vivo whole blood survival assays have been used widely as models of invasive 410 
meningococcal disease [52-55]. They are considered to be useful as they are relatively facile 411 
and reproduce many of the important constituents of the host-pathogen interaction using cells 412 
from the host relevant to this highly human-adapted pathogen. Killing of N. meningitidis in a 413 
whole blood survival assay is mediated by both cellular and humoral components of the 414 
immune system, although capsulated N. meningitidis are protected from complement-415 
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mediated killing in the absence of specific antibody. It has also been shown recently that the 416 
presence of heparin, as used in our assay to prevent coagulation, may also reduce 417 
complement-mediated killing [56]. The observation that the prx5-grx mutant was more 418 
sensitive to killing than its wild-type parent is unlikely to be explained by differences in 419 
sensitivity to H2O2 as this mutant was less sensitive in an H2O2 killing assay. It also cannot be 420 
explained by changes in levels of plasminogen binding, which might act to inhibit 421 
interactions with phagocytes, as the mutant cells bound as much plasminogen as their wild-422 
type parents in ELISA assays, presumably due to the presence of other identified 423 
plasminogen-binding proteins on the meningococcal surface. The mechanism by which Prx5-424 
Grx promotes meningococcal survival remains to be determined, but our findings 425 
demonstrate that it is likely to play an important role in invasive meningococcal disease.  426 
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Fig. 1. rPrx5-Grx is a plasminogen-binding protein. (A) Binding of rPrx5-Grx to 436 
immobilized human ligands examined by ELISA. rPrx5-Grx bound significantly to glu-plg 437 
compared to the negative control immobilized ligand (BSA). ** P value < 0.01 (Student’s t-438 
test). Binding of rPrx5-Grx to laminin, fibronectin or collagen was not significantly different 439 
to BSA. (B) Binding of rPrx5-Grx to glu-plg in the presence or absence of 50 mM ϵ-440 
aminocapronic acid (EACA). * P value < 0.05 (Student’s t-test) compared to binding in the 441 
absence of EACA. Means are from ≥ 4 independent experiments carried out in triplicate 442 






Fig. 2. Lysine 244 is required for optimal binding of rPrx5-Grx to plasminogen. No 445 
significant differences were detected in the ability of rPrx5-GrxK230A and rPrx5-GrxC185A to 446 
bind glu-plg compared to rPrx5-Grx as determined by ELISA. The significant reduction in 447 
binding of rPrx5-GrxK230A, K244A and rPrx5-GrxK244A shows that lysine 244 is required for 448 
optimal glu-plg binding. BSA was used as a negative control. *, **, *** denote P values < 449 
0.05, < 0.01 and < 0.001, respectively (Student’s t-test) compared to rPrx5-Grx. Means are 450 





Fig. 3. Detection of surface-exposed meningococcal Prx5-Grx by whole-cell ELISA. 454 
Wells were coated with formaldehyde-fixed whole meningococcal cells before being probed 455 
with rabbit anti-rPrx5-Grx antibodies. Binding of the antiserum was significantly reduced in 456 
strains lacking wild-type levels of rPrx5-Grx expression. Complementation of prx5-grx 457 
restored expression, albeit not to wild-type levels. Values shown are minus 458 
the values obtained from control wells coated with 1% BSA. *** and **** denote P values < 459 
0.001 and < 0.0001, respectively (Student’s t-test) compared to MC58. Means are from ≥ 4 460 





Fig. 4. Loss of surface-localized Prx5-Grx does not significantly reduce the ability of 464 
meningococci to bind plasminogen. No significant differences were detected in the ability 465 
of the MC58 strains tested to bind glu-plg. In each case, the addition of ϵ-aminocapronic acid 466 
(EACA) abolished the interaction confirming that all significant interactions at the 467 
meningococcal surface with glu-plg are lysine-mediated. **** denote P value < 0.0001 468 
(Student’s t-test) compared to MC58 rpsL-. Means are from ≥ 3 independent experiments 469 





Fig. 5. Prx5-Grx deficient meningococci have increased tolerance to hydrogen peroxide. 473 
Meningococcal cells were resuspended in BHI broth and exposed to a final concentration of 474 
12.5 mM H2O2. After 20 min of exposure, the survival of MC58 rpsL
- prx5-grx was 475 
significantly higher (Student’s t-test p value < 0.05) than MC58 rpsL-. With the exception of 476 
MC58 rpsL- prx5-grx, all strains were undetectable at 40 and 60 min. Three experiments, 477 







Fig. 6. Prx5-Grx is important for survival in an ex vivo human whole blood model of 483 
meningococcal septicemia. Results show the survival of strains in human whole blood from 484 
two different donors (A and B) over the course of 2 h. There was a ≥ 2-log10 difference in 485 
CFU between MC58 rpsL- prx5-grx and the parental or complemented strain at the 30 and 486 
60 min time points. Each donor sample was tested twice in duplicate. Error bars indicate SE 487 
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